600422 昆药集团
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.2168.6517.84710.99610.567
总资产报酬率 ROA (%)1.2254.6814.1825.9675.873
投入资产回报率 ROIC (%)1.7786.6655.8638.5908.737

边际利润分析
销售毛利率 (%)41.18944.82041.51641.30143.156
营业利润率 (%)7.9647.3806.0037.6827.008
息税前利润/营业总收入 (%)8.3207.4506.2258.1307.472
净利润/营业总收入 (%)6.5305.8964.6546.2185.989

收益指标分析
经营活动净收益/利润总额(%)115.49797.60493.56067.23580.709
价值变动净收益/利润总额(%)0.3083.2543.49023.7122.659
营业外收支净额/利润总额(%)0.168-0.865-4.161-0.437-0.064

偿债能力分析
流动比率 (X)1.9261.9291.7401.7731.779
速动比率 (X)1.4561.4661.3081.2331.230
资产负债率 (%)43.03742.74645.47844.44743.332
带息债务/全部投入资本 (%)14.36915.14120.59219.10312.999
股东权益/带息债务 (%)561.517526.927360.966393.235627.971
股东权益/负债合计 (%)128.142129.559116.170121.017126.459
利息保障倍数 (X)24.31255.88513.45916.90515.963

营运能力分析
应收账款周转天数 (天)134.499116.55293.51171.02564.979
存货周转天数 (天)143.513142.666132.455133.796129.208